Why is Enzymatica AB ?
1
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -46.35%, its profits have risen by 5.3%
2
Underperformed the market in the last 1 year
- Even though the market (OMX Stockholm 30) has generated returns of 10.97% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -46.35% returns
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Enzymatica AB for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Enzymatica AB
-46.35%
-0.10
60.48%
OMX Stockholm 30
10.97%
0.59
18.59%
Quality key factors
Factor
Value
Sales Growth (5y)
-13.49%
EBIT Growth (5y)
-214.88%
EBIT to Interest (avg)
-30.72
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.41
Sales to Capital Employed (avg)
0.38
Tax Ratio
0.15%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.61
EV to EBIT
-8.89
EV to EBITDA
-8.89
EV to Capital Employed
4.76
EV to Sales
9.46
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-53.50%
ROE (Latest)
-36.86%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Movement
7What is working for the Company
NET PROFIT(HY)
Higher at SEK -19.43 MM
ROCE(HY)
Highest at -34.53%
NET SALES(Q)
Highest at SEK 18.33 MM
-1What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 10.58% (YoY
Here's what is working for Enzymatica AB
Net Profit
Higher at SEK -19.43 MM
than preceding 12 month period ended Dec 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (SEK MM)
Net Sales
Highest at SEK 18.33 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (SEK MM)
Net Sales
At SEK 18.33 MM has Grown at 39.08%
over average net sales of the previous four periods of SEK 13.18 MMMOJO Watch
Near term sales trend is positive
Net Sales (SEK MM)
Here's what is not working for Enzymatica AB
Raw Material Cost
Grown by 10.58% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






